Can a smartphone app ease the burden on home palliative caregivers?
NCT ID NCT07654998
First seen Jun 24, 2026 · Last updated Jul 28, 2026 · Updated 3 times
Summary
This study tests whether a mobile health app can help family caregivers of patients receiving home palliative care. 120 caregivers will either use the app for 6 weeks or receive usual care alone. The app provides education on symptom management, daily care, and stress relief. Researchers will measure caregiver competence, burden, and patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mobile health application
- What this could lead to
- If it works, this app could make caregiving easier and less stressful for families looking after loved ones at home.
- What could go wrong
- This is a small, early-stage trial with 120 participants. The app may not improve caregiver skills or reduce hospital visits as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Family caregiver of a patient receiving home palliative care services. * Aged 18 years or older. * Providing unpaid care to the patient for at least 3 months. * Able to read and understand Turkish. * Owns or has regular access to a smartphone compatible with the mobile application. * Willing to participate and provide written informed consent. Exclusion Criteria: * Professional or paid caregivers. * Participation in another structured caregiver support program during the study period. * Cognitive, visual, or hearing impairments that would prevent effective use of the mobile application. * Inability to complete study assessments. * Withdrawal of consent at any stage of the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Simav Doc. Dr. Ismail Karakuyu State Hospital
RECRUITINGSimav, Kütahya, 43500, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?